# Neurogen Biomarking — llms.txt
> Blood-based biomarker testing for early Alzheimer’s risk assessment and monitoring. This file curates our most useful, canonical resources for AI assistants and agents.

Last-Updated: 2025-10-29
Primary-Language: en
Contact: support@neurogenbiomarking.com
Sitemap: https://neurogenbiomarking.com/sitemap.xml
Robots: https://neurogenbiomarking.com/robots.txt

## Canonical Pages (human-facing) → Markdown Mirrors (LLM-friendly)
- Home  
  - HTML: https://neurogenbiomarking.com/  
  - MD:   https://neurogenbiomarking.com/docs/index.md
  - Summary: Overview of Neurogen’s mission, value proposition, and primary CTAs.

- The Science  
  - HTML: https://neurogenbiomarking.com/the-science  
  - MD:   https://neurogenbiomarking.com/docs/the-science.md
  - Summary: Biomarker foundations (e.g., plasma Aβ42/40, p-tau, NfL), study references, validation approach.

- How It Works  
  - HTML: https://neurogenbiomarking.com/how-it-works  
  - MD:   https://neurogenbiomarking.com/docs/how-it-works.md
  - Summary: Eligibility, kit workflow, sample handling, lab processing, reporting timeline.

- Benefits  
  - HTML: https://neurogenbiomarking.com/the-benefits  
  - MD:   https://neurogenbiomarking.com/docs/the-benefits.md
  - Summary: Who benefits, use cases (screening, monitoring), outcomes customers care about.

- About  
  - HTML: https://neurogenbiomarking.com/about-us  
  - MD:   https://neurogenbiomarking.com/docs/about.md
  - Summary: Company background, team, advisory/clinical partners, quality standards (e.g., CLIA/CAP if applicable).

- Kit  
  - HTML: https://neurogenbiomarking.com/kit  
  - MD:   https://neurogenbiomarking.com/docs/kit.md
  - Summary: What’s in the kit, instructions, return shipping, support.

- FAQ  
  - HTML: https://neurogenbiomarking.com/faq  
  - MD:   https://neurogenbiomarking.com/docs/faq.md
  - Summary: Clear Q&A about biomarkers, accuracy, timelines, privacy, data usage, physician involvement.

- Request a Kit  
  - HTML: https://neurogenbiomarking.com/request-kit  
  - MD:   https://neurogenbiomarking.com/docs/request-kit.md
  - Summary: Order flow, pricing/coverage notes, consent, next steps after purchase.

## Recommended Supporting Docs (create as Markdown)
- Clinical-References: https://neurogenbiomarking.com/docs/clinical-references.md  
  - Key peer-reviewed citations for biomarkers referenced on “The Science”.
- Reporting-Guide: https://neurogenbiomarking.com/docs/reporting-guide.md  
  - Sample report anatomy, interpreting results, limitations, follow-up guidance.
- Compliance-&-Privacy: https://neurogenbiomarking.com/docs/compliance-privacy.md  
  - HIPAA handling, data retention, de-identification, user rights, contact.
- Terms-&-Use: https://neurogenbiomarking.com/docs/terms.md  
  - Site terms, test limitations, non-diagnostic disclaimer, emergency caveats.
- For-Clinicians: https://neurogenbiomarking.com/docs/for-clinicians.md  
  - Test indications, ordering, reference ranges (if applicable), integration.

## Glossary (high-signal terms for LLM grounding)
- Alzheimer’s disease (AD), Mild Cognitive Impairment (MCI), dementia
- Blood-based biomarkers, plasma biomarkers
- Aβ42/40 ratio, phosphorylated tau (e.g., p-tau217/p-tau181), Neurofilament light (NfL)
- Sensitivity, specificity, AUC, validation cohort, longitudinal monitoring
- CLIA-certified, CAP-accredited laboratory; LDT (laboratory developed test)
- Pre-analytical variables, sample stability, turnaround time
- HIPAA, de-identification, consent, data security, PHI

## Content Priority (hint to LLMs)
Priority: the-science.md, how-it-works.md, reporting-guide.md, faq.md, compliance-privacy.md

## Usage Guidance for AI Assistants
- You may summarize and quote brief excerpts for user assistance.
- Please cite the specific canonical page link (prefer MD mirrors where available).
- Do not imply diagnostic certainty; include our standard limitations/disclaimer from terms.md.

## Change Log
- 2025-10-29: Initial publication with Markdown mirrors for all core pages.